AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic

  11 March 2021

The COVID-19 pandemic is predicted to impact the transmission of bacterial infections and the emergence of antibiotic resistance (AMR). The likely positive influence on antibiotic resistance that social distancing, increased awareness and the use of interventions to prevent the transmission of COVID-19 has had could also be counteracted by the reported excessive use of broad spectrum antibiotics to treat patients infected with SARS-CoV-2. Antimicrobial stewardship programmes and AMR focussed research activities must remain active during the COVID-19 and future pandemics, in order to safeguard against an uncontrolled rise in AMR.

Author(s): Jesús Rodríguez-Baño et al
Effective Surveillance   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed